IMPORTANT DISCLOSURE REGARDING PAID EXPERTS AND MATERIAL NON-PUBLIC INFORMATION:
JMP has adopted certain policies and procedures to verify that our featured experts can identify “material non-public information” and that they will not divulge any such information during our discussion. Such experts are required, among other things, to certify that they have no other conflict, contractual or otherwise, that would make their presentation contrary to any rule, law or regulation.
Dr. Patrick Ott has been vetted and approved by JMP’s Research and/or Compliance Department for participation in JMP Securities Hematology and Oncology Summit December 6-7.
Dr. Patrick Ott was the Primary Investigator or co-PI on clinical trials testing personalized vaccines sponsored by Genentech (Roche) and Neon.